Cargando…
Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial
OBJECTIVES: To compare the efficacy and safety of poractant alfa and bovine lipid extract surfactant in preterm infants. STUDY DESIGN: Randomized, partially-blinded, multicenter trial. Infants <32 weeks needing surfactant before 48 hours were randomly assigned to receive poractant alfa or bovine...
Autores principales: | Lemyre, Brigitte, Fusch, Christoph, Schmölzer, Georg M., Rouvinez Bouali, Nicole, Reddy, Deepti, Barrowman, Nicholas, Huneault-Purney, Nicole, Lacaze-Masmonteil, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417427/ https://www.ncbi.nlm.nih.gov/pubmed/28472058 http://dx.doi.org/10.1371/journal.pone.0175922 |
Ejemplares similares
-
The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning
por: Pezzi, Mario, et al.
Publicado: (2020) -
Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
por: Jeon, Ga Won, et al.
Publicado: (2015) -
Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets
por: Rey-Santano, Carmen, et al.
Publicado: (2020) -
Poractant alfa (Curosurf(®)) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo
por: Willems, Coen HMP, et al.
Publicado: (2012) -
In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits
por: Guo, Xiaojing, et al.
Publicado: (2020)